S65487

· Servier

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for S65487, covering 2024-10-16 to 2025-04-11. Get the full timeline:

Most recent: Clinical Trial Update: Phase I/II Trial of S65487 Plus Azacitidine in Acute Myeloid Leukemia [Phase 1, Phase 2]